Results

1–5 of 5 results for OAKS and DERBY

Impact of AREDS Oral Micronutrient Supplementation on Geographic Atrophy Progression: Insights From thePhase 3 OAKS and DERBY Trials
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2025
Baseline Characteristics Associated With Geographic Atrophy Progression in the OAKS and DERBY Trials
Srinivas Reddy Sadda, MD
Annual Meeting Talks
2025
Exudative Age-Related Macular Degeneration Events from the OAKS and DERBY Clinical Trials of Pegcetacoplan in Geographic Atrophy
Roger A. Goldberg, MD, MBA
Annual Meeting Talks
2023
Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD, FASRS
Annual Meeting Talks
2022
Detailed Baseline Demographics and Disease Characteristics of Patients With Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials
On Demand Cases, Courses, and Papers
2022